NeoBase Non-derivatized Assay Solutions - This reagent package is intended for sample - Wallac Oy

Duns Number:540156544

Device Description: This reagent package is intended for sample processing in the assay of in vitro measuremen This reagent package is intended for sample processing in the assay of in vitro measurement and evaluation of the concentrations of amino acids, succinylacetone and acylcarnitines in dried blood spot samples (DBS) on filter paper.This reagent package is used together with the NeoBase Non-derivatized MSMS Kit and the NeoBase Succinylacetone Assay Solution.

Want to know more about this Product? Request more information now!


More Product Details

Catalog Number

3041-0020

Brand Name

NeoBase Non-derivatized Assay Solutions

Version/Model Number

3041-0020

Device Commercial Distribution Status

In Commercial Distribution

Commercial Distribution End Date

-

Issuing Agency

In GS1

Product Characteristics

MRI safety Status

Labeling does not contain MRI Safety Information

Device required to be labeled as containing natural rubber latex or dry natural rubber (21 CFR 801.437)

-

Device labeled as "Not made with natural rubber latex"

-

For Single-Use

-

Prescription Use (Rx)

-

Over the Counter (OTC)

-

Kit

-

Combination Product

-

Human Cell, Tissue or Cellular or Tissue-Based Product (HCT/P)

-

FDA Premarket Submission

K083130,K093916

Product Code Details

Product Code

NQL

Product Code Name

System, Test, Amino Acids, Free Carnitines And Acylcarnitines Tandem Mass Spectrometry

Device Record Status

Public Device Record Key

aeac7032-350b-42f3-b05b-e343587c5397

Public Version Date

December 13, 2018

Public Version Number

5

DI Record Publish Date

February 11, 2016

Additional Identifiers

Package DI Number

None

Quantity per Package

-

Contains DI Package

-

Package Discontinue Date

-

Package Status

-

Package Type

-

"WALLAC OY" Characteristics
Device Class Device Class Description No of Devices
1 A medical device with low to moderate risk that requires general controls 57
2 A medical device with a moderate to high risk that requires special controls. 38
3 A medical device with high risk that requires premarket approval 2